Patents Assigned to IROA Technologies LLC
  • Patent number: 11977008
    Abstract: In mass spectrometry significant error is introduced during sample preparation (sample-to-sample error), during ion generation (ion suppression), and during ion transmission (ion transmission losses). We demonstrate the ability to correct for ion suppression and ion transmission losses, and that once corrected for ion losses, a sample-to-sample normalization of the analytical sample to the internal standard is possible. By normalizing to a standard sample the analytical sample becomes completely comparable to any similarly treated sample.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: May 7, 2024
    Assignee: IROA TECHNOLOGIES, LLC.
    Inventors: Christopher William Ward Beecher, Felice de Jong
  • Publication number: 20220317000
    Abstract: In mass spectrometry significant error is introduced during sample preparation (sample-to-sample error), during ion generation (ion suppression), and during ion transmission (ion transmission losses). We demonstrate the ability to correct for ion suppression and ion transmission losses, and that once corrected for ion losses, a sample-to-sample normalization of the analytical sample to the internal standard is possible. By normalizing to a standard sample the analytical sample becomes completely comparable to any similarly treated sample.
    Type: Application
    Filed: June 15, 2022
    Publication date: October 6, 2022
    Applicant: IROA Technologies LLC
    Inventors: Christopher William Ward Beecher, Felice de Jong
  • Patent number: 11371918
    Abstract: In mass spectrometry significant error is introduced during sample preparation (sample-to-sample error), during ion generation (ion suppression), and during ion transmission (ion transmission losses). We demonstrate the ability to correct for ion suppression and ion transmission losses, and that once corrected for ion losses, a sample-to-sample normalization of the analytical sample to the internal standard is possible. By normalizing to a standard sample the analytical sample becomes completely comparable to any similarly treated sample.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: June 28, 2022
    Assignee: Iroa Technologies, LLC
    Inventors: Christopher William Ward Beecher, Felice de Jong
  • Publication number: 20220037139
    Abstract: An IROA Matrix of metabolite compounds is disclosed. Each of whose compounds has a molecular weight of 2000 AMU or less, and is present as first and second isotopomers that are equally present at two predetermined isotopomeric balances, and contain 2 to 10% of a first isotope, and 90 to 98% of a second isotope, respectively. A reagent pair for transforming a natural abundance mass spectral analysis metabolite sample into an IROA sample is also disclosed and comprises two reactively identical reagents that constitute first and second isotopomers containing 2 to 10% of a first isotope, and 90 to 98% of a second isotope, respectively. Each of the reagent pair contains the same reactive group that reacts with and bonds to a functional group of one or more compounds present in a composition of biologically-produced metabolite compounds. Methods of making and using the above and related materials are also disclosed.
    Type: Application
    Filed: May 14, 2021
    Publication date: February 3, 2022
    Applicant: IROA Technologies, LLC
    Inventors: Christopher Beecher, Richard A. Yost, Robin Hendrikus Johannes Kemperman
  • Patent number: 8536520
    Abstract: A method for identifying a biological analyte that is affected by a stressor is disclosed in which two substantially identical biological samples are provided, with a first sample being a control sample and a second sample being an experimental sample. The control sample is grown with a nutrient having an isotope of a first atom, whereas the experimental sample is grown with a nutrient having a second isotope of the first atom. The experimental sample is grown with a stressing agent and regimen. The samples are admixed, and the formed composite is mass spectroscopically assayed for analyte peaks. The ratio of first isotope to second isotope is determined for the peaks, as is a sample median isotopic ratio. The ratio for assayed analyte peaks is compared with the median ratio. An analyte whose isotopic ratio significantly deviates from the median ratio is an analyte affected by the stressing agent.
    Type: Grant
    Filed: October 25, 2010
    Date of Patent: September 17, 2013
    Assignee: IROA Technologies LLC
    Inventor: Christopher William Ward Beecher